Literature DB >> 25201903

The Feasibility of LigaSure to Create Intestinal Anastomosis: Results of Ex Vivo Study.

Mario Santini1, Alfonso Fiorelli2, Gaetana Messina2, Antonio Mazzella2, Marina Accardo3.   

Abstract

OBJECTIVE: To evaluate the feasibility and the effectiveness of LigaSure Forced Triad to create intestinal anastomosis in an ex vivo porcino model.
METHODS: Colon samples (n = 100) were prospectively randomized into 2 groups: LigaSure group (n = 90) and Stapler group (n = 10). The LigaSure group was divided into 9 subgroups, each of 10 samples, according to the different power levels of the LigaSure system (Bar 1, Bars 2, and Bars 3) and radiofrequency application (1 application, 2 applications, and 3 applications) used. All anastomoses were tested for early burst pressure. The LigaSure subgroup having the highest burst pressure was compared with the Stapler group. Finally, the specimen was reviewed by the same pathologist.
RESULTS: The burst pressures of the 9 subgroups of LigaSure segments were the following: 29.7 ± 4.5 (Subgroup a); 27.4 ± 3.1 (Subgroup b); 25.3 ± 4 (Subgroup c); 32.9 ± 2.3 (Subgroup d); 30.7 ± 3.8 (Subgroup e); 25.7 ± 4.8 (Subgroup f); 42 ± 4.7 (Subgroup g); 31.8 ± 3.8 (Subgroup h); and 28.5 ± 3 (Subgroup j). Subgroup g (3 bars-power levels/1 frequency application) had the highest burst pressure (P < .001; ANOVA test). No significant difference was found between burst pressure of Subgroup g and Stapler group (42 ± 4.7 vs 42 ± 4.3, respectively, P = .9). On histological view, the LigaSure anastomosis was formed by collagen sealed without cavitation defects.
CONCLUSIONS: Our study seems to confirm the feasibility of creating intestinal anastomosis using LigaSure. However, further researches in in vivo models are mandatory before recommending its clinical usage in such settings.
© The Author(s) 2014.

Entities:  

Keywords:  LigaSure; anastomosis; bipolar vessel sealing system; colon

Mesh:

Year:  2014        PMID: 25201903     DOI: 10.1177/1553350614547771

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  6 in total

Review 1.  The Beneficial Effects of Physical Activity in Lung Cancer Prevention and/or Treatment.

Authors:  Gaetana Messina; Nicola Tartaglia; Antonio Ambrosi; Chiara Porro; Angelo Campanozzi; Anna Valenzano; Gaetano Corso; Alfonso Fiorelli; Rita Polito; Mario Santini; Marcellino Monda; Domenico Tafuri; Giovanni Messina; Antonietta Messina; Vincenzo Monda
Journal:  Life (Basel)       Date:  2022-05-25

Review 2.  The Potential Role of Nutrition in Lung Cancer Establishment and Progression.

Authors:  Chiara Porro; Maria Ester La Torre; Nicola Tartaglia; Tarek Benameur; Mario Santini; Antonio Ambrosi; Giovanni Messina; Giuseppe Cibelli; Alfonso Fiorelli; Rita Polito; Gaetana Messina
Journal:  Life (Basel)       Date:  2022-02-12

3.  Evaluation of the LigaSure(™) Vessel Sealing System for bowel transection and intestinal anastomosis-an experimental study in a porcine model.

Authors:  Tobias Gehrig; A T Billeter; A L Wekerle; M Shevchenko; K Brand; B P Müller-Stich
Journal:  Langenbecks Arch Surg       Date:  2016-03-23       Impact factor: 3.445

4.  Management of residual spaces after lung resections and air leaks: Ultrasound and pneumoperitoneum.

Authors:  Gaetana Messina; Antonio Noro; Giovanni Natale; Mary Bove; Morena Fasano; Giovanni Vicidomini; Mario Santini; Alfonso Fiorelli
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15

5.  In vivo evaluation of Mg-6Zn and titanium alloys on collagen metabolism in the healing of intestinal anastomosis.

Authors:  Xiao-Hu Wang; Jian-Shu Ni; Nai-Long Cao; Song Yu; Yi-Gang Chen; Shao-Xiang Zhang; Bao-Jun Gu; Jun Yan
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

6.  Ex-Vivo Evaluation of "First Tip Closing" Radiofrequency Vessel Sealing Devices for Swine Small Intestinal Transection.

Authors:  Luca Lacitignola; Alberto Crovace; Giuseppe Passantino; Francesco Staffieri
Journal:  Vet Sci       Date:  2022-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.